Shenzhen Rivaroxaban Co.,Ltd
Home
About us
Products
Rivaroxaban
Pharmaceutical Intermediates
Tegprazan
VeMurafenib
Anti-diabetic
Antiviral Drug
Antidepressants
Anti-cancer Drugs
High Polymer Materials
Complementary Medicines
Cardiovascular Medications
News
Blog
Contact us
Language
English
Français
Deutsch
Español
Italiano
Português
日本語
한국어
Русский
Home
>
News
LATEST NEWS
ORIN
Aarti Industries Limited Approves Final Dividend for the Financial Year Ended March 31, 2023
Improving treatment for hairy cell leukemia
For Your Patients: Choosing the Right Therapy for Advanced Melanoma
Glenmark Pharmaceuticals gets ANDA approval for its anti
Aug 12, 2023
ORIN
read more +
Aug 10, 2023
Aarti Industries Limited Approves Final Dividend for the Financial Year Ended March 31, 2023
read more +
Aug 08, 2023
Improving treatment for hairy cell leukemia
read more +
Aug 06, 2023
For Your Patients: Choosing the Right Therapy for Advanced Melanoma
read more +
Aug 04, 2023
Glenmark Pharmaceuticals gets ANDA approval for its anti
read more +
Aug 02, 2023
Artemisinin attenuates type 2 diabetic cardiomyopathy in rats through modulation of AGE
read more +
Jul 31, 2023
Dahlia flower extract has anti
read more +
Jul 29, 2023
How to Get Wegovy in 2023
read more +
Jul 27, 2023
Studies Examine Links Between Diabetes and Eye Disease, Treatment, Adverse Events
read more +
Jul 25, 2023
Influence of rutin and its combination with metformin on vascular functions in type 1 diabetes
read more +
Jul 23, 2023
Wellbutrin vs. Lexapro: Which Is Right For You?
read more +
Jul 21, 2023
The drug smugglers keeping HIV patients alive in South Africa
read more +
first
1
2
3
4
5
last